Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage

Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus... Correspondence AIDS 2018, 32:531 – 535 Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage The incidence of the hepatitis A virus (HAV) is increasing far lower in HIV-negative MSMs taking PrEP: 61% were in Europe [1]. Sixteen European countries have reported seronegative. Between 25 March and 31 July 2017, all but 1500 cases of confirmed HAVand 2660 cases of probable one HAV seronegative patient who could be contacted or suspected HAV since June 2016: the cases mostly received HAV vaccination. We vaccinated 32 HIV- involved adult MSM. Confirmed cases were related to positive MSMs and 18 MSMs taking PrEP. After the first three distinct clusters of genotype IA. In France, increased dose of vaccine, anti-HAV antibodies were found in 85% cases of HAV have been reported within the Paris area of vaccinated individuals. since January 2017 and this outbreak is now spreading to other regions of France [2]. HAV immunization of individuals, including those that had received a first dose of vaccine, increased from 76% to In our hospital, 257 HIV-positive MSMs and 31 HIV- 84% in HIV-positive MSMs and from 20 to 89% in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AIDS Wolters Kluwer Health

Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage

Loading next page...
 
/lp/wolters_kluwer/acute-hepatitis-a-breakthrough-in-msm-in-paris-area-implementation-of-bdLYog6kkN
Publisher
Wolters Kluwer
Copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0269-9370
eISSN
1473-5571
D.O.I.
10.1097/QAD.0000000000001715
Publisher site
See Article on Publisher Site

Abstract

Correspondence AIDS 2018, 32:531 – 535 Acute hepatitis A breakthrough in MSM in Paris area: implementation of targeted hepatitis A virus vaccine in a context of vaccine shortage The incidence of the hepatitis A virus (HAV) is increasing far lower in HIV-negative MSMs taking PrEP: 61% were in Europe [1]. Sixteen European countries have reported seronegative. Between 25 March and 31 July 2017, all but 1500 cases of confirmed HAVand 2660 cases of probable one HAV seronegative patient who could be contacted or suspected HAV since June 2016: the cases mostly received HAV vaccination. We vaccinated 32 HIV- involved adult MSM. Confirmed cases were related to positive MSMs and 18 MSMs taking PrEP. After the first three distinct clusters of genotype IA. In France, increased dose of vaccine, anti-HAV antibodies were found in 85% cases of HAV have been reported within the Paris area of vaccinated individuals. since January 2017 and this outbreak is now spreading to other regions of France [2]. HAV immunization of individuals, including those that had received a first dose of vaccine, increased from 76% to In our hospital, 257 HIV-positive MSMs and 31 HIV- 84% in HIV-positive MSMs and from 20 to 89% in

Journal

AIDSWolters Kluwer Health

Published: Feb 20, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off